KIT and gastrointestinal stromal tumor: KIT proto-oncogene, receptor tyrosine kinase (KIT, ~69%-83%) or platelet-derived growth factor receptor A (PDGFRA, ~5%-10%) oncogene mutations are the primary drivers in GIST pathogenesis.